|
Real-time Estimate
Cboe BZX
12:13:00 28/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 446.73 USD | +0.47% |
|
+1.75% | +36.45% |
| 11:56pm | FDA warns Amgen over cancer drug promotional video | RE |
| 26/10 | European Stocks Close Higher in Monday Trading as Oil Prices Ease, Bond Yields Stabilize | MT |
| Market Cap | 24TCr 22TCr 20TCr 18TCr 34TCr 22,83300Cr 34TCr 2,38800Cr 95TCr 11,96800Cr 90TCr 88TCr 37,95200Cr | P/E 2026 * |
28.2x | P/E 2027 * | 25.2x |
|---|---|---|---|---|---|
| Enterprise Value | 28TCr 25TCr 23TCr 21TCr 40TCr 26,76100Cr 40TCr 2,79900Cr 1,11200Cr 14,02700Cr 1,05800Cr 1,03500Cr 44,48200Cr | EV / Sales 2026 * |
7.23x | EV / Sales 2027 * | 6.83x |
| Free-Float |
99.77% | Yield 2026 * |
2.27% | Yield 2027 * | 2.4% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| AMGN | Delayed | |
CBOE
| AMGN | Real-time | |
|
Tradegate
| AMG | Real-time | |
|
Xetra
| AMG | Delayed | |
|
Boerse Muenchen
| AMG | Real-time | |
|
Deutsche Boerse AG
| AMG | Delayed | |
|
London S.E.
| 0R0T | Delayed | |
|
Berne S.E.
| 000907582 | End-of-day quote | |
|
Mexican S.E.
| AMGN * | End-of-day quote | |
|
Borsa Italiana
| 1AMGN | End-of-day quote | |
|
Börse Stuttgart
| AMG | Delayed | |
|
Wiener Boerse
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGN | End-of-day quote | |
|
Santiago S.E.
| AMGNCL | End-of-day quote | |
|
CBOE
| 0R0T | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Amgen Inc.
| 1 day | +0.47% | ||
| 1 week | +1.75% | ||
| Current month | +5.95% | ||
| 1 month | +6.81% | ||
| 3 months | +18.70% | ||
| 6 months | +31.28% | ||
| Current year | +36.45% |
| 1 week | 434.53 |  | 450.98 |
| 1 month | 396.01 | | 450.98 |
| Current year | 318.21 | | 450.98 |
| 1 year | 288 | | 450.98 |
| 3 years | 249.7 | | 450.98 |
| 5 years | 198.64 | | 450.98 |
| 10 years | 133.64 | | 450.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CEO | Chief Executive Officer | 63 | 01/05/2012 |
| Director of Finance/CFO | 62 | 13/05/2010 | |
Paul Burton
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/06/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Bradway
CHM | Chairman | 63 | 01/01/2013 |
Tyler Jacks
BRD | Director/Board Member | 65 | 01/01/2012 |
Robert Eckert
BRD | Director/Board Member | 71 | 01/01/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 01/09/26 | Other | Chief Financial Officer | 34,061 | 0.0063% | ||
| 13/08/26 | Exercice | Executive/Senior Manager | 3,756 | 0.0007% | ||
| 07/08/26 | Free | Director | 85 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.47% | +1.75% | +53.39% | +70.74% | 24TCr | |
| +0.06% | -0.35% | +54.78% | +128.32% | 1,14000Cr | |
| +0.94% | +3.54% | +41.12% | +84.44% | 64TCr | |
| -0.07% | -0.92% | +25.60% | +106.15% | 51TCr | |
| +0.63% | +2.33% | +49.21% | +67.82% | 38TCr | |
| +0.89% | -4.26% | +61.35% | +38.09% | 35TCr | |
| +1.02% | +1.80% | +24.84% | +53.75% | 29TCr | |
| -0.25% | +1.62% | +2.20% | +26.65% | 27TCr | |
| -0.59% | +0.92% | +31.11% | +106.15% | 20TCr | |
| -0.36% | -0.65% | -23.68% | -60.69% | 17TCr | |
| Average | +0.24% | +2.78% | +31.99% | +62.14% | 41.86TCr | |
| Weighted average by Cap. | +0.29% | +2.92% | +39.33% | +82.10% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.9TCr 3.5TCr 3.23TCr 2.93TCr 5.47TCr 3,70100Cr 5.54TCr 39TCr 15TCr 1,94000Cr 15TCr 14TCr 6,15300Cr | 4.04TCr 3.62TCr 3.35TCr 3.03TCr 5.67TCr 3,83600Cr 5.74TCr 40TCr 16TCr 2,01100Cr 15TCr 15TCr 6,37600Cr |
| Net income | 855.55Cr 767.85Cr 709Cr 642.93Cr 1.2TCr 81TCr 1.22TCr 8.5TCr 3.38TCr 43TCr 3.21TCr 3.14TCr 1,35100Cr | 943.88Cr 847.13Cr 782.2Cr 709.32Cr 1.33TCr 90TCr 1.34TCr 9.38TCr 3.72TCr 47TCr 3.54TCr 3.47TCr 1,49000Cr |
| Net Debt | 4.14TCr 3.71TCr 3.43TCr 3.11TCr 5.81TCr 3,92800Cr 5.88TCr 41TCr 16TCr 2,05900Cr 16TCr 15TCr 6,53000Cr | 3.53TCr 3.17TCr 2.93TCr 2.65TCr 4.96TCr 3,35300Cr 5.02TCr 35TCr 14TCr 1,75800Cr 13TCr 13TCr 5,57400Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 27/26/27 | $446.76 | +0.48% | 7,94,019 |
| 26/26/26 | $444.63 | +1.22% | 20,53,000 |
| 23/26/23 | $439.26 | -1.79% | 20,74,548 |
| 22/26/22 | $447.28 | +2.04% | 31,05,002 |
| 21/26/21 | $438.34 | -0.14% | 26,10,626 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- AMGN Stock
Select your edition
All financial news and data tailored to specific country editions
